Yahoo Finance's Josh Lipton breaks down the market trends for March 11, 2025 including rising concern that tariff uncertainty could cause more layoffs in the auto industry, Trump's meeting with business leaders at the White House, plus the future of Elon Musk and Tesla. #youtube #stocks #tesla About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.
SAN DIEGO, CA / ACCESSWIRE / July 23, 2024 / CeCors, Inc. (OTC PINK:CEOS) ("CeCors" or the "Company"), through its wholly-owned subsidiary VETCOMM, a leading veteran claims benefit company, is excited to announce the development of its new VETCOMM App and digital workbook designed to assist veterans in navigating the VA claims process. This strategic pivot from our previous focus on telehealth services with PsyKey Live to dedicated veteran support demonstrates our commitment to serving those who served us.
CARSON, CA / ACCESSWIRE / May 16, 2024 / CeCors, Inc. (the "Company" or "CEOS") (OTC PINK:CEOS), a vertically integrated company focused on diverse operating channels, including the rapidly expanding veterans' services and benefits operations of its subsidiary VETCOMM, is proud to report a strong start to the 2024 year with expectations of ongoing developments in its strategic growth initiatives. In the first quarter of 2024, CEOS achieved total new sales for the quarter of approximately $1,030,000.
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Michael Maher CEO | OTC PINK Exchange | 150043107 CUSIP |
| CA Country | 6 Employees | - Last Dividend | 26 Aug 2008 Last Split | - IPO Date |
Psykey, Inc. is a pioneering entity in the sphere of entheogenic, adaptogenic, and nootropic ingredients and formulations, striving to enhance and optimize life through its functional product lines. Initially known as CeCors, Inc., the company underwent a rebranding to Psykey, Inc. in August 2021, marking a new chapter in its mission toward researching, developing, and commercializing cutting-edge health solutions. Founded in 2002 and headquartered in Toronto, Canada, Psykey, Inc. stands at the forefront of the psychedelic market, dedicating its efforts to the development of technologies aimed at the composition, bioavailability, and targeted delivery of entheogen-based therapeutics. Through continuous innovation, Psykey, Inc. seeks to unlock the therapeutic potential of psychedelic substances, offering a range of products designed to improve mental health, well-being, and overall life quality.
Psykey, Inc. offers an innovative line of functional mushroom coffees and teas. These beverages are infused with carefully selected mushrooms known for their health benefits, including cognitive enhancement, immune support, and stress reduction. Each product is crafted to deliver a unique blend of flavor and functionality, catering to the modern consumer's desire for wellness-oriented alternatives to traditional beverages.
The company extends its expertise into the production of oral supplements. These supplements are formulated with a mix of entheogenic, adaptogenic, and nootropic ingredients, designed to support various facets of health and well-being. With a focus on enhancing mental clarity, stamina, and stress resilience, Psykey, Inc.'s supplements offer a holistic approach to health optimization.
Complementing its range of functional beverages, Psykey, Inc. also provides single serve drink mixes. These convenient, on-the-go products are perfect for consumers seeking immediate, easy-to-consume solutions with the same health-promoting properties as the company's coffees, teas, and supplements. Whether for a mid-day boost or post-workout recovery, these drink mixes cater to a wide array of needs and lifestyles.